Home > Drugs A-Z > WHITE ASH POLLEN

WHITE ASH POLLEN (Allergy Laboratories, Inc.)

Available Formats

Dosage Form Package Information Links
INJECTION, SOLUTION 10 mL in 1 VIAL, MULTI-DOSE (54575-906-10) Label Information
INJECTION, SOLUTION 2 mL in 1 VIAL, MULTI-DOSE (54575-906-02) Label Information
INJECTION, SOLUTION 50 mL in 1 VIAL, MULTI-DOSE (54575-906-50) Label Information
INJECTION, SOLUTION 30 mL in 1 VIAL, MULTI-DOSE (54575-906-30) Label Information

Complete WHITE ASH POLLEN Information

  • BOXED WARNING(What is this?)

    WARNINGS

    This product is intended for use by physicians who are experienced in the administration of allergenic extracts and the emergency care of anaphylaxis, or for use under the guidance of an allergy specialist.

    Patients should be instructed to recognize adverse reaction symptoms and cautioned to contact physicians’ office if reaction symptoms occur. As with all allergenic extracts, severe systemic reactions may occur. In certain individuals these life threatening reactions may be fatal. Patients should be observed for at least 20 to 30 minutes following treatment and emergency measures as well as personnel trained in their use should be immediately available in the event of a life threatening reaction. Serious adverse reactions can be reported to the US Food and Drug Administration MedWatch, 5600 Fishers Lane, Rockville, Maryland 20852-9787, (800) FDA-1088, or www.fda/gov/medwatch.

    This product should not be injected intravenously. Patients who are taking non-selective beta blockers may be more reactive to allergens given for testing and may be unresponsive to the usual doses of epinephrine used to treat allergic reactions. Refer to the Warnings, Precautions, Adverse Reactions and Dosage sections below.


  • SPL UNCLASSIFIED SECTION

    Allergenic Extracts

    Directions for Use


  • DESCRIPTION

    Therapeutic extracts (concentrates) are designed primarily for the physician equipped to prepare dilutions and mixtures as necessary. Allergenic Extracts are manufactured from various biological allergenic source materials including pollens, molds, epidermals, insects, food and environmental inhalants. The extraction is performed in a glycerin solution and the resulting concentration is expressed as weight to volume (w/v) ratio. This is the weight of dry pollen in grams to volume of glycerin extracting solution in milliliters. Extracts are filtered and sterile filled. Tests include those for safety and sterility. The route of administration is subcutaneous. Scratch diagnostic extracts are of the same therapeutic extract formulation and their route of administration is percutaneous. Intradermal diagnostic extracts are dilutions of the therapeutic extracts using Sterile Diluent for Allergenic Extract.

    Inactive ingredients:
    Therapeutic and Scratch extracts:      Intradermal 1:500 v/v (foods)             Intradermal 1:1,000 v/v (pollens, molds, epidermals, inhalants)  
    Glycerin, USP, 50% v/v Glycerin, USP, 0.1% v/v Glycerin, USP, 0.05% v/v
    Sodium chloride, USP, 0.166% w/v Sodium chloride, USP, 0.9% w/v Sodium chloride, USP, 0.9% w/v      
    Sodium bicarbonate, USP, 0.091% w/v Sodium bicarbonate, USP, 0.000182% w/v Sodium bicarbonate, USP, 0.000091% w/v
    Phenol, USP, 0.4%       w/v Phenol, USP, 0.4% w/v
    Sterile Diluent for Allergenic Extract:   
    Normal Saline with Phenol:     Human Serum Albumin:  Glycerin, USP, 50% w/v 
    Sodium chloride, USP 0.9% w/v Sodium chloride, USP 0.9% w/v Sodium bicarbonate, USP 0.091% w/v
    Phenol, USP 0.4% w/v       Phenol, USP 0.4% w/v Sodium chloride, USP 0.166% w/v
    Water for Injection, USP q.s. Normal Serum Albumin (Human), 0.03% w/v Water for Injection, USP, q.s.
    Air replaced with Nitrogen, NF Water for Injection, USP q.s.
    Air replaced with Nitrogen, NF

    The following allergenic extracts are designated and labeled “FOR DIAGNOSTIC USE ONLY”. Data to support the therapeutic use of these extracts has not been established:             Coffee             Cottonseed       Flaxseed             Housefly             Mosquito

    The strength of Standardized Short Ragweed and Ragweed Mix, Giant and Short extracts is described (in addition to w/v) as antigen E content. The concentration of antigen E per milliliter of the final preparation as determined by radial immunodiffusion (RID). The antigen E content of an extract is influenced by several variables. These include antigen E content of the pollen, nature of extracting solutions, ratio of pollen weight to volume of extracting solution and storage conditions. Variables which influence antigen E stability during storage conditions include nature of the solvent, antigen E concentration and storage temperature. Glycerin is a stabilizer of antigen E and other allergens.


  • CLINICAL PHARMACOLOGY

    Allergenic extracts for diagnostic testing produce erythema or erythema and wheal reactions in patients with significant IgE-mediated sensitivity to the relevant allergen. This allergic inflammatory response, although not completely understood, is thought to begin with the reaction of antigen with IgE on the surface of basofils, or mast cells, which initiates a series of biochemical events resulting in the production of histamine and other mediators. These, in turn, produce the immediate-type “wheal and flare” skin reaction. The more mediator released, the larger the reaction. Because of a variety of factors, including the types of allergen extracts, delayed skin reactions can occur and usually disappear within a couple of days. The type of extract, size of the reaction and timing of the reaction are all factors used in determining a patient’s sensitivity to an allergen.

    Allergen immunotherapy (also known as desensitization, hyposensitization, allergy vaccination, or allergy shots) involves treating a patient with increasing dosage of the allergens to which he is allergic, eventually reaching a dose plateau whereas the patient experiences an increased tolerance upon re-exposure to the allergens. The patient may or may not need to receive continued treatment to demonstrate the desensitization. The exact mechanisms of reaction of desensitization with allergens, which involve the allergen, IgE and IgG antibodies, mast cells and basophils and possibly other mediators, are not completely understood. However, efficacy has been shown in numerous well-controlled studies using specific common allergens.

    The goals of allergen immunotherapy are to decrease the production of IgE antibodies, initiate the production of IgG antibodies and stabilize mast cells and basophils. Overproduction of IgE in response to an allergen can induce other cells, particularly mast cells and basophils, to initiate a complex chain reaction that results in allergy symptoms. Numerous IgE receptor sites are located on mast cells as well as basophil cells. These cells are among the first cells to be encountered by the antigen. They contain potent chemical mediators (histamine and leukotriene, for example) of inflammation that are released when IgE and a specific allergen cross-link on the cell surface. The release of the chemical mediators results in inflammation and allergy symptoms. As a response to immunotherapy, the production of IgG is believed to work by blocking IgE from binding to mast cells and basophils. Thus IgG, the blocking antibody, may prevent the release of chemical mediators that produce allergy symptoms.


  • INDICATIONS AND USAGE

    Immunotherapy using allergenic extracts is indicated for use in patients with severe allergy symptoms (hay fever, rhinitis, etc.) to pollens, molds, insects, animal danders and various other allergens. Immunotherapy is intended for patients whose symptoms are not satisfactorily controlled by avoidance of the offending allergen or by the use of symptomatic medications. Treatment uses only those specific allergens that the patient is sensitive to based on diagnostic tests and medical history. It is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.


  • CONTRAINDICATIONS

    There are no known absolute contraindications to diagnostic testing or hyposensitization with allergen immunotherapy. 

    Patients with cardiovascular disease or pulmonary disease such as symptomatic asthma, and/or who are receiving cardiovascular drugs such as beta blockers, may be at higher risk for severe adverse reactions. These patients may also be more refractory to the normal anaphylaxis treatment regimen.

    Immunotherapy is not generally indicated when the offending allergen(s) can be effectively eliminated or minimized by environmental control. There are differences of opinion on the possibility of routine immunizations exacerbating autoimmune diseases. The evidence has been inconclusive. Therefore, caution should be exercised in administering immunotherapy to patients with other immunologic diseases and only administered if the risk from exposure to the allergen is greater than the risk of exacerbating the underlying disorder. Injections should be avoided in patients with a bleeding tendency.


  • WARNINGS

    See boxed WARNINGS at the beginning of this information sheet.

    Do not administer allergenic extract injections intravenously. Patients should always be observed for at least 20 to 30 minutes after any skin test or injection. Concentrated allergenic extracts should be diluted with Sterile Diluent for Allergenic Extract prior to use for intradermal testing and for immunotherapy preparation. Systemic reactions may occur infrequently and may range from mild exaggeration of the patient’s allergic symptoms to urticaria, rhinitis, conjunctivitis, angioedema, cough, wheezing, fainting, pallor, bradycardia, hypotension, or even, in extremely sensitive individuals, to anaphylactic shock and death. Have epinephrine 1:1,000 readily available in case of a reaction. Emergency measures and personnel trained for medical emergencies should be immediately available in the event of a life-threatening reaction. Patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater risk. Patients taking beta-blocker medication may not respond to the usual dose of epinephrine.

    Diagnostic testing as well as immunotherapy should be temporarily withheld from patients or the dose reduced until cause of reaction is evaluated by prescribing physician if any of the following conditions exist: (1) severe symptoms of rhinitis and/or asthma, (2) infection or flu accompanied by fever, (3) exposure to excessive amounts of clinically relevant allergen prior to a scheduled injection, and (4) systemic reaction to previous injection.


  • PRECAUTIONS

    (1) GENERAL

    The presence of asthmatic signs and symptoms may be an indicator of severe reaction following allergen injections. Any evidence of a local or generalized reaction requires a dose reduction during the initial stages of immunotherapy, as well as during maintenance therapy. Patient reactions to previous injections should be reviewed before each new injection and a conservative dosage schedule should be followed until a pattern of local responses is established which can be used to monitor increases in dosage. Patients should be observed in the office for at least 20 to 30 minutes after each treatment injection and instructed to seek medical attention if symptoms of a systemic reaction occur. Most severe reactions will occur within this time period, and rapid treatment measures should be initiated (see ADVERSE REACTIONS). In rare circumstances, a patient may have systemic reactions to minute doses of antigen and does not demonstrate increasing tolerance to injections after several months of treatment. If systemic reactions or excessive local responses occur persistently at very small doses, efforts at immunotherapy should be stopped.

    When changing lots of extracts, even though the formulation may be the same, the first dose should not exceed 50% of the previous dose as the extract may have lost potency over time and a fresh extract could have an effective potency that is substantially greater than that of the old extract. Aseptic technique should always be used when injections of allergenic extracts are administered.

    (2) INFORMATION FOR PATIENTS

    Patients should be instructed to remain in the office for 20 to 30 minutes after each injection to monitor for adverse reactions. Patients should be instructed to describe any active allergic symptoms such as rhinitis, wheezing, dyspnea, etc. prior to injection including any late reactions from previous administration.

    (3) DRUG INTERACTIONS

    Beta-Blockers: Patients who are taking non-selective beta blockers may be more reactive to allergens given for testing and may be unresponsive to the usual doses of epinephrine used to treat allergic reactions. Patients with cardiovascular diseases and/or pulmonary diseases such as symptomatic unstable, steroid-dependent asthma, and/or those who are receiving cardiovascular drugs such as beta-blockers, may be at higher risk for severe adverse reactions.

    Antihistamines can significantly inhibit the immediate skin test reactions. If long acting antihistamines have been taken recently, it is recommended that they should be stopped for the following minimum intervals before skin testing is performed: 1 week for hydroxyzine or cetirizine; 4 to 7 days for loratadine; 3 to 4 days for fexofenadine; and 24 to 48 hours for other sustained release antihistamines.

    (4) CARCINOGENISIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY

    Long term studies with allergenic extracts have not been conducted in animals to determine their potential for carcinogenesis, mutagenesis, or impairment of fertility.

    (5) PREGNANCY – CATEGORY C

    Animal reproduction studies have not been conducted with allergenic extracts. It is also not known whether allergenic extracts can cause fetal harm when administered to a pregnant woman or if they can affect reproduction capacity. The physician must weigh the benefits of immunotherapy against the risk of anaphylactic reactions that could result in harm to the mother and/or fetus. Hyposensitization should be used during pregnancy only if clearly necessary and administered cautiously.

    (6) NURSING MOTHERS  

    It is not known if allergenic extracts appear in human milk. Because many drugs are excreted in human milk, caution should be exercised when allergenic extracts are administered to a nursing woman.

    (7) PEDIATRIC USE

    Extracts have not been studied in children, so the safety in children has not been established. Doses of allergenic extracts for children are generally the same as those for adults. In the case of large doses, the amount of extract given to a child may be modified so that the discomfort of the injection is minimized.


  • ADVERSE REACTIONS

    (1) Local Reactions - A mild burning immediately after the injection is to be expected; this usually subsides in 10 to 20 seconds. Reactions at the site of injection (erythema, swelling, pruritus) may be immediate or delayed. Immediate wheal and erythema reactions are ordinarily of little consequence; but if very large, may be the first manifestation of a systemic reaction. Delayed reactions start several hours after injection with local edema, erythema, itching or pain. The reactions are most apparent 24 hours after injection and usually require no treatment. Antihistamines may be administered orally if necessary. Large local reactions may be treated by local applications of cold, wet dressings and/or the use of oral antihistamines. These reactions should be considered a warning of possible severe systemic reaction and need for temporarily reduced dosage. In such cases the next therapeutic dose should be reduced to the last dose which did not elicit a reaction and subsequent doses increased more slowly.

    (2) Systemic Reactions - Most severe systemic reactions occur within 30 minutes of injection but may occur at anytime subsequent to treatment. Symptoms may range from mild to life-threatening (due to anaphylaxis). Systemic reactions are characterized by one or more of the following symptoms: sneezing, mild to severe generalized urticaria, itching other than at the injection site, extensive or generalized edema, wheezing, asthma, dyspnea, cyanosis, tachycardia, lacrimation, marked perspiration, cough, hypotension, syncope and upper airway obstruction. Symptoms may progress to anaphylactic shock and death.

    If a systemic or anaphylactic reaction does occur, apply a tourniquet above the site of injection and inject 1:1,000 epinephrine-hydrochloride intramuscularly into the opposite arm or gluteal area. Loosen the tourniquet at least every 10 minutes. Do not obstruct arterial blood flow with the tourniquet.

    1:1,000 EPHEDRINE DOSAGE: 

    ADULT: 0.3 mL to 0.5 mL should be injected intramuscularly or subcutaneously. Repeat in 5 to 10 minutes if necessary.

    PEDIATRIC: Suggested dosage for infants to 2 years of age is 0.05 mL to 0.1 mL; for children 2 to 6 years, 0.15 mL; and children 6 to 12 years, 0.2 mL.

    Doses may be repeated every 20 minutes, depending on the severity of the condition and the response of the patient. After administration of epinephrine, profound shock or vasomotor collapse should be treated with intravenous fluids, and vasoactive drugs if necessary. An open airway should be insured. Give oxygen by mask. Intravenous antihistamine, inhaled bronchodilators, theophyllin and/or adrenal corticosteroids may be used if necessary after adequate epinephrine and circulatory support has been given. Emergency resuscitation measures and personnel trained in their use must be available immediately in the event of a serious systemic or anaphylactic reaction not responsive to the above measures.

    If the patient is continued on immunotherapy, a decrease of at least 50% in the next dose should follow serious systemic reactions. Increases in dose should be made cautiously. Repeated systemic reactions are sufficient reason for discontinuation of increased dosages.  

    (3) To report suspected ADVERSE REACTIONS, contact Allergy Laboratories, Inc. 800-654-3971 or FDA 800-FDA-1088 or www.fda/gov/medwatch.


  • OVERDOSAGE      

    Signs and symptoms of overdose are typically local and systemic reactions. For a description and management of overdose reactions, see ADVERSE REACTIONS.


  • DOSAGE AND ADMINISTRATION

    Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

    Allergenic extracts may be administered for diagnostic testing or therapeutic purposes. The dosage will depend on the particular use of the extract.

    General: When used for diagnostic testing to determine a patient’s sensitivity to specific antigens and aid in the diagnosis and treatment of atopic disease, the recommended procedure is to initially perform puncture tests, then follow with intradermal tests. The number of skin tests applied at one time will depend on the particular patient and their allergic history. These tests should be performed and observed in 15 to 20 minutes. Additional tests may be applied in sequence. Perform tests on the anterolateral aspect of the upper arm on an area that permits the effective application of a tourniquet proximal to the site of the test. The skin at the site of injection should be disinfected with rubbing alcohol before testing. A positive reaction usually develops in 15 to 20 minutes. The positive response is a wheal and flare reaction that is larger than the negative control and evaluated based on the size of the reaction.

    Controls: A negative control containing the same solution that the extract was prepared in should be applied to a test site in the same manner as the tests being performed. Histamine phosphate should be used as a positive control for evaluation of skin testing. Refer to manufacturers directions provided with Histamine phosphate for recommended dosage and administration.

    Percutaneous testing: In general, skin is scratched, punctured or pricked just before the allergen is applied or through a drop of test allergen which is placed on the skin. There are several devices available for this technique. Refer to the device manufacturers instructions for proper use. Test areas should be no closer than 4-5 cm apart to avoid the interference of multiple reactions. Clean test areas with alcohol and air dry. Place the allergen on the volar surface of the patient’s forearm, upper arm, or back.

    1. For puncture tests, apply one drop of extract to the skin. Pierce the drop of extract and skin using a sterile hypodermic needle or vaccinating needle. Maintain the needle perpendicular to the skin surface and rock the needle back and forth to produce a small hole without bleeding. Do not rotate or gouge the needle. Remove needle from skin and wipe excess extract from skin surface.

    2. For scratch tests using a scarifier or needle: make a scratch 1/16 inch long on the epidermis penetrating the outer cornified area but being careful not to draw blood. Apply one drop of allergen to the scratch or puncture.

    Intracutaneous (Intradermal) testing: If puncture test is negative, proceed with intradermal test. Intradermal tests should not be performed if puncture test is positive. Use a separate sterile syringe (tuberculin type equipped with a 27 gauge by 3/8 inch needle with intradermal bevel) for each antigen. To administer the test, inject 0.02 mL of allergen into the epidermis using dilutions of the concentrated extract; a 1:500 v/v dilution for foods and 1:1,000 v/v dilution for other extracts. If the test has been performed properly, the solution should raise a bleb 2 to 3 mm in diameter. If the bleb does not appear, the injection was made too deeply. To prepare intradermal testing strengths using 1:20 w/v bulk concentrates, use the following example: Add 1 mL of 1:20 w/v to 4 mL diluent to make a 1:100 v/v dilution. Add 1 mL of 1:100 v/v to 4 mL diluent to make a 1:500 v/v dilution. Add 0.5 mL of 1:100 v/v dilution to 4.5 mL diluent to make a 1:1,000 v/v dilution.

    Interpretation of results:
    Percutaneous tests Intradermal tests 1
    1+ Erythema with 5mm wheal 0 <5mm Erythema with a <5mm wheal      
    2+ Erythema with a 5-10mm wheal       +/- 5-10mm Erythema with a 5-10mm wheal
    3+ Erythema with a 10-15mm wheal 1+ 11-20mm Erythema with a 5-10mm wheal
    4+ Erythema with a wheal 15mm or larger with pseudopodia     2+ 21-30mm Erythema with a 5-10mm wheal
    3+ 31-40mm Erythema with a 10-15mm wheal or with pseudopodia   
    4+ >40mm Erythema with >15mm wheal or with pseudopodia

    Immunotherapy:                  

    (1) General: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Injections are given subcutaneously; preferably in the arm. It is advantageous to give injections in alternate arms. Use sterile precautions and a tuberculin syringe when administering each dose. Allergen immunotherapy is typically initiated with a diluted formulation of allergens prescribed by a physician for administration to a patient. Doses are gradually increased over time and ultimately reach a maintenance dose where the patient is maintained for as long as the physician or patient feels is necessary. The formulation and dosage schedule is determined by the physician and is based on diagnostic testing and patient history. Patients with very high sensitivities should be initiated with lower concentrations (higher dilutions) and may need a very relaxed progression to maintenance doses. Pre-seasonal therapy may be initiated three months before seasonal difficulty begins and brought to maintenance dose and discontinued after that season ends. Perennial therapy (recommended) brings the patient up to tolerated maintenance dose where they remain until improvement of allergic symptoms occurs. Injections may be given at intervals of 4 to 7 days with either therapy.

    (2) Suggested dilution series: Concentrated Allergenic Extracts must be diluted with Sterile Diluent for Allergenic Extract before using for immunotherapy. A 1:100,000 v/v dilution of concentrate is usually satisfactory to start treatment.  To prepare a 10-fold dilution series from concentrated bulk extract, the following is suggested:  Add 1 mL of 1:20 w/v extract to 4 mL diluent to make a 1:100 v/v dilution. Add 0.5 mL of the 1:100 dilution to 4.5 mL of diluent to make a 1:1,000 v/v dilution. Add 0.5 mL of the 1:1,1000 dilution to 4.5 mL diluent to make a 1:10,000 v/v dilution. Add 0.5 mL of the 1:10,000 dilution to 4.5 mL of diluent to make a 1:100,000 v/v dilution. The series may be extended to 1:1,000,000 v/v by preparing one more similar dilution as a precaution for sensitive patients.  

    (3) Maintenance: The maintenance level is the largest dose tolerated by the patient that relieves symptoms without producing undesirable local or general reactions. After immunotherapy has been established, a maintenance dose should be given at weekly intervals. The interval between maintenance doses can be increased gradually from one week to 10 days, to 2 weeks, 3 weeks, or even 4 weeks as allergy symptoms allow. Repeat maintenance doses at a given interval three or four times to check for continued allergy symptom relief before increasing the interval further. If large local (or systemic) reactions occur at one interval, do not increase the interval. Protection is lost rapidly if the interval between doses is more than 4 weeks. It may not be possible for all patients to reach the maximum dose indicated on the suggested dosage schedule.

    (4) Suggested dosage schedule: Because the degree of sensitivity varies in many individuals, the dose and interval may need adjustment and should reflect the patient’s tolerance and response. A dose should never be given until all reactions resulting from a previous dose have entirely disappeared. After a period on immunotherapy, better tolerance may permit a longer interval between injections, or a larger maintenance dose, or both.

    1:100,000 v/v 1:10,000 v/v 1:1,000 v/v       1:100 v/v
    Dose Vol. (mL)  Dose Vol. (mL)            Dose Vol. (mL)   Dose Vol. (mL) Maintenance
    1 0.02 8 0.02 13 0.02 19 0.02
    2 0.04 9 0.05 14 0.05 20 0.05 Continue 0.25 mL of 1:100 v/v weekly.
    3 0.06 10 0.10 15 0.10 21 0.08
    4 0.10 11 0.15 16 0.15 22 0.10
    5 0.15 12 0.25 17 0.20 23 0.15
    6 0.20 18 0.25 24 0.20
    7 0.25 25 0.25

         

    (5) Dose adjustments: Since the individual components of the extract are those to which the patient is allergic and to which he will be exposed, typical allergic symptoms may follow shortly after the injection, particularly those experienced by the patient during exposure when the antigen from the environment plus the injected antigen exceeds the patient’s tolerance to the antigen. In such cases, decrease the size of the next scheduled dose by at least one-half of the previous dose.

    (6) Administration: Use aseptic precautions when diluting and/or preparing an injection. To avoid cross-contamination, do not use the same needle to withdraw materials from multiple vials. Use a sterile tuberculin syringe (26 or 27 gauge) with a needle at least 5/8” long and graduated in 0.01 mL units to measure each dose.


  • HOW SUPPLIED

    Bulk extract (stock concentrate) in 50% v/v glycerin is supplied in 10 mL, 30 mL, and 50 mL multiple dose vials as well as 2 mL scratch (dropper) vials. Intradermal tests are supplied in 5 mL vials at 1:500 v/v for food extracts and at 1:1,000 v/v for other extracts.

     


  • STORAGE

    To insure the maximum potency of bulk extract and extract dilutions, it is recommended that they be maintained at a temperature of 2 to 8 degrees Celsius.  Do not freeze. Do not use after the expiration date shown on the vial label.


  • REFERENCES

    1. Norman, P.S.: In vivo methods of study of allergy: Skin and Mucosal tests, techniques, and interpretation. In Middleton, E. Jr., Reed, C. E. and Ellis, E.F. (ed): Allergy Principles and Practice, (Vol. 1), p. 258. St. Louis, The C.V. Mosby Co. 1978.

    ALLERGY LABORATORIES, INC.
    U.S. License # 103
    Oklahoma City, OK 73109
    (800) 654-3971, (405) 235-1451

    Rev. 12/2010


  • PRINCIPAL DISPLAY PANEL

    PRINCIPAL DISPLAY PANEL
    ALLERGENIC EXTRACT

    RX ONLY

    PRINCIPAL DISPLAY PANEL
ALLERGENIC EXTRACT
RX ONLY


  • PRINCIPAL DISPLAY PANEL

    PRINCIPAL DISPLAY PANEL

    ALLERGENIC EXTRACT

    SCRATCH TESTING

    RX ONLY

    PRINCIPAL DISPLAY PANEL
ALLERGENIC EXTRACT
SCRATCH TESTING
RX ONLY


  • INGREDIENTS AND APPEARANCE
    APPLE 
    apple injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-335
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    APPLE (UNII: B423VGH5S9) (APPLE - UNII:B423VGH5S9) APPLE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-335-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-335-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-335-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-335-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    APRICOT 
    apricot injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-336
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    APRICOT (UNII: 269CJD5GZ9) (APRICOT - UNII:269CJD5GZ9) APRICOT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-336-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-336-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-336-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-336-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    AVOCADO 
    avocado injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-338
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AVOCADO (UNII: SDS87L369F) (AVOCADO - UNII:SDS87L369F) AVOCADO 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-338-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-338-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-338-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-338-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BANANA 
    banana injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-339
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BANANA (UNII: 4AJZ4765R9) (BANANA - UNII:4AJZ4765R9) BANANA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-339-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-339-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-339-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-339-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BLACKBERRY 
    blackberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-353
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACKBERRY (UNII: 8A6OMU3I8L) (BLACKBERRY - UNII:8A6OMU3I8L) BLACKBERRY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-353-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-353-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-353-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-353-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BLUEBERRY 
    blue ridge blueberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-354
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLUE RIDGE BLUEBERRY (UNII: 89Y9MUH0K5) (BLUE RIDGE BLUEBERRY - UNII:89Y9MUH0K5) BLUE RIDGE BLUEBERRY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-354-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-354-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-354-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-354-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CANTALOUPE 
    cantaloupe injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-360
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CANTALOUPE (UNII: 8QF5D5H6UH) (CANTALOUPE - UNII:8QF5D5H6UH) CANTALOUPE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-360-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-360-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-360-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-360-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CHERRY FOOD 
    cherry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-371
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHERRY (UNII: BUC5I9595W) (CHERRY - UNII:BUC5I9595W) CHERRY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-371-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-371-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-371-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-371-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CRANBERRY 
    cranberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-383
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CRANBERRY (UNII: 0MVO31Q3QS) (CRANBERRY - UNII:0MVO31Q3QS) CRANBERRY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-383-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-383-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-383-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-383-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    DATE 
    date injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-387
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DATE (UNII: H3O7QI5HY7) (DATE - UNII:H3O7QI5HY7) DATE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-387-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-387-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-387-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-387-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BASIL 
    basil injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-341
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BASIL (UNII: 2U0KZP0FDW) (BASIL - UNII:2U0KZP0FDW) BASIL 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-341-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-341-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-341-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-341-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GRAPEFRUIT 
    grapefruit injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-399
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GRAPEFRUIT (UNII: O82C39RR8C) (GRAPEFRUIT - UNII:O82C39RR8C) GRAPEFRUIT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-399-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-399-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-399-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-399-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BLACK BASS 
    largemouth bass injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-342
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LARGEMOUTH BASS (UNII: XC209ITL3J) (LARGEMOUTH BASS - UNII:XC209ITL3J) LARGEMOUTH BASS 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-342-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-342-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-342-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-342-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    LEMON 
    lemon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-406
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LEMON (UNII: 24RS0A988O) (LEMON - UNII:24RS0A988O) LEMON 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-406-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-406-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-406-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-406-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    LIME 
    lime, citrus injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-408
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIME (CITRUS) (UNII: 8CZS546954) (LIME (CITRUS) - UNII:8CZS546954) LIME (CITRUS) 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-408-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-408-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-408-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-408-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    ORANGE FOOD 
    orange injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-423
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ORANGE (UNII: 5EVU04N5QU) (ORANGE - UNII:5EVU04N5QU) ORANGE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-423-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-423-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-423-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-423-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    PEACH 
    peach injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-432
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEACH (UNII: 3OKE88I3QG) (PEACH - UNII:3OKE88I3QG) PEACH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-432-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-432-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-432-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-432-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PEAR 
    pear injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-434
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEAR (UNII: 2ZN8DWC0YF) (PEAR - UNII:2ZN8DWC0YF) PEAR 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-434-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-434-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-434-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-434-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PINEAPPLE 
    pineapple injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-440
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINEAPPLE (UNII: 2A88ZO081O) (PINEAPPLE - UNII:2A88ZO081O) PINEAPPLE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-440-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-440-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-440-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-440-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PINTO BEAN 
    kidney bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-346
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-346-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-346-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-346-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-346-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BEEF 
    beef injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-350
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BEEF (UNII: 4PIB2155QP) (BEEF - UNII:4PIB2155QP) BEEF 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-350-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-350-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-350-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-350-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    STRAWBERRY 
    strawberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-462
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STRAWBERRY (UNII: 4J2TY8Y81V) (STRAWBERRY - UNII:4J2TY8Y81V) STRAWBERRY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-462-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-462-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-462-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-462-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    CATFISH 
    catfish injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-365
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CATFISH (UNII: EFN1AL1YP0) (CATFISH - UNII:EFN1AL1YP0) CATFISH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-365-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-365-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-365-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-365-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    WATERMELON 
    watermelon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-474
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WATERMELON (UNII: 231473QB6R) (WATERMELON - UNII:231473QB6R) WATERMELON 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-474-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-474-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-474-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-474-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CHICKEN FOOD 
    chicken injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-372
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHICKEN (UNII: 0X8Q245Y7B) (CHICKEN - UNII:0X8Q245Y7B) CHICKEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-372-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-372-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-372-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-372-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CLAM 
    quahog injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-375
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUAHOG (UNII: 226LY0AFR9) (QUAHOG - UNII:226LY0AFR9) QUAHOG 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-375-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-375-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-375-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-375-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    RED KIDNEY BEAN 
    kidney bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-347
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-347-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-347-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-347-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-347-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    LIMA BEAN 
    lima bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-344
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIMA BEAN (UNII: 112YH1ZMX2) (LIMA BEAN - UNII:112YH1ZMX2) LIMA BEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-344-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-344-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-344-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-344-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    NAVY BEAN 
    kidney bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-345
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-345-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-345-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-345-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-345-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GREEN STRING BEAN 
    string bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-349
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STRING BEAN (UNII: N9D69B2Q7Y) (STRING BEAN - UNII:N9D69B2Q7Y) STRING BEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-349-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-349-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-349-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-349-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CODFISH 
    cod injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-379
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COD (UNII: 8D6Q5LNG3D) (COD - UNII:8D6Q5LNG3D) COD 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-379-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-379-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-379-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-379-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BROCCOLI 
    broccoli injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-356
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROCCOLI (UNII: UOI4FT57BZ) (BROCCOLI - UNII:UOI4FT57BZ) BROCCOLI 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-356-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-356-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-356-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-356-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CRAB MEAT 
    blue crab injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-382
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLUE CRAB (UNII: 8J18RFO4A8) (BLUE CRAB - UNII:8J18RFO4A8) BLUE CRAB 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-382-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-382-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-382-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-382-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BRUSSEL SPROUTS 
    brussels sprout injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-357
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BRUSSELS SPROUT (UNII: KHX46H31F8) (BRUSSELS SPROUT - UNII:KHX46H31F8) BRUSSELS SPROUT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-357-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-357-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-357-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-357-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CABBAGE 
    cabbage injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-359
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CABBAGE (UNII: GW0W1Y9I97) (CABBAGE - UNII:GW0W1Y9I97) CABBAGE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-359-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-359-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-359-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-359-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CARROT 
    carrot injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-362
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARROT (UNII: L56Z1JK48B) (CARROT - UNII:L56Z1JK48B) CARROT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-362-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-362-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-362-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-362-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CAULIFLOWER 
    cauliflower injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-366
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CAULIFLOWER (UNII: 138LUT2DWV) (CAULIFLOWER - UNII:138LUT2DWV) CAULIFLOWER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-366-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-366-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-366-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-366-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CELERY 
    celery injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-367
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CELERY (UNII: 44IDY6DTKX) (CELERY - UNII:44IDY6DTKX) CELERY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-367-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-367-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-367-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-367-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    EGG WHITE 
    egg white injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-389
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGG WHITE (UNII: 3E0I92Z2GR) (EGG WHITE - UNII:3E0I92Z2GR) EGG WHITE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-389-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-389-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-389-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-389-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CUCUMBER 
    cucumber injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-385
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUCUMBER (UNII: YY7C30VXJT) (CUCUMBER - UNII:YY7C30VXJT) CUCUMBER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-385-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-385-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-385-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-385-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    WHOLE EGG 
    egg injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-390
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGG (UNII: 291P45F896) (EGG - UNII:291P45F896) EGG 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-390-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-390-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-390-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-390-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GREEN PEPPER 
    green bell pepper injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-437
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GREEN BELL PEPPER (UNII: 4J4DOU3HEK) (GREEN BELL PEPPER - UNII:4J4DOU3HEK) GREEN BELL PEPPER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-437-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-437-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-437-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-437-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    EGG YOLK 
    egg yolk injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-391
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGG YOLK (UNII: 4IPS17B70T) (EGG YOLK - UNII:4IPS17B70T) EGG YOLK 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-391-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-391-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-391-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-391-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    LETTUCE 
    lettuce injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-407
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LETTUCE (UNII: 5PO6NN3RRJ) (LETTUCE - UNII:5PO6NN3RRJ) LETTUCE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-407-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-407-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-407-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-407-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    MUSHROOM FOOD 
    cultivated mushroom injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-414
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CULTIVATED MUSHROOM (UNII: 54C8E6W6JY) (CULTIVATED MUSHROOM - UNII:54C8E6W6JY) CULTIVATED MUSHROOM 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-414-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-414-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-414-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-414-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    FLOUNDER 
    flounder injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-394
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FLOUNDER (UNII: T197LO581X) (FLOUNDER - UNII:T197LO581X) FLOUNDER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-394-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-394-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-394-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-394-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GREEN OLIVE 
    green olive injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-420
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GREEN OLIVE (UNII: 6HD2W46UEG) (GREEN OLIVE - UNII:6HD2W46UEG) GREEN OLIVE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-420-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-420-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-420-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-420-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    ONION 
    onion injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-422
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ONION (UNII: 492225Q21H) (ONION - UNII:492225Q21H) ONION 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-422-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-422-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-422-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-422-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PARSLEY 
    parsley injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-428
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PARSLEY (UNII: 58FMD0Q0EV) (PARSLEY - UNII:58FMD0Q0EV) PARSLEY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-428-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-428-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-428-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-428-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GREEN PEA 
    pea injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-431
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEA (UNII: W4X7H8GYFM) (PEA - UNII:W4X7H8GYFM) PEA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-431-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-431-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-431-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-431-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SWEET POTATO 
    sweet potato injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-444
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SWEET POTATO (UNII: M9WGG9Z9GK) (SWEET POTATO - UNII:M9WGG9Z9GK) SWEET POTATO 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-444-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-444-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-444-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-444-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    WHITE POTATO 
    potato injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-445
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POTATO (UNII: CFE1S8DYWD) (POTATO - UNII:CFE1S8DYWD) POTATO 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-445-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-445-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-445-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-445-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GRAPE 
    concord grape injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-398
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CONCORD GRAPE (UNII: T3PW93IB4Q) (CONCORD GRAPE - UNII:T3PW93IB4Q) CONCORD GRAPE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-398-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-398-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-398-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-398-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    RADISH 
    radish injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-449
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RADISH (UNII: EM5RP35463) (RADISH - UNII:EM5RP35463) RADISH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-449-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-449-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-449-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-449-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    RHUBARB 
    rhubarb injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-451
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RHUBARB (UNII: G280W4MW6E) (RHUBARB - UNII:G280W4MW6E) RHUBARB 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-451-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-451-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-451-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-451-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SOYBEAN 
    soybean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-348
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SOYBEAN (UNII: L7HT8F1ZOD) (SOYBEAN - UNII:L7HT8F1ZOD) SOYBEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-348-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-348-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-348-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-348-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SPINACH 
    spinach injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-460
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SPINACH (UNII: 6WO75C6WVB) (SPINACH - UNII:6WO75C6WVB) SPINACH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-460-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-460-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-460-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-460-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    YELLOW SQUASH 
    squash injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-461
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SQUASH (UNII: 9961HBA483) (SQUASH - UNII:9961HBA483) SQUASH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-461-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-461-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-461-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-461-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    TOMATO 
    tomato injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-466
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TOMATO (UNII: Z4KHF2C175) (TOMATO - UNII:Z4KHF2C175) TOMATO 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-466-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-466-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-466-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-466-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    HADDOCK 
    haddock injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-400
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HADDOCK (UNII: 0WLY635722) (HADDOCK - UNII:0WLY635722) HADDOCK 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-400-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-400-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-400-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-400-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    HALIBUT 
    pacific halibut injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-401
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PACIFIC HALIBUT (UNII: BKZ683617P) (PACIFIC HALIBUT - UNII:BKZ683617P) PACIFIC HALIBUT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-401-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-401-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-401-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-401-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    COW MILK 
    cow milk injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-412
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COW MILK (UNII: 917J3173FT) (COW MILK - UNII:917J3173FT) COW MILK 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-412-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-412-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-412-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-412-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CASHEW NUT 
    cashew injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-364
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CASHEW (UNII: 3H5U5CX7KO) (CASHEW - UNII:3H5U5CX7KO) CASHEW 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-364-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-364-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-364-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-364-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    COCONUT 
    coconut injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-378
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCONUT (UNII: 3RT3536DHY) (COCONUT - UNII:3RT3536DHY) COCONUT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-378-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-378-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-378-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-378-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    ENGLISH WALNUT FOOD 
    english walnut injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-473
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ENGLISH WALNUT (UNII: 1V3SHR7QB7) (ENGLISH WALNUT - UNII:1V3SHR7QB7) ENGLISH WALNUT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-473-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-473-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-473-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-473-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BLACK PEPPER 
    black pepper injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-436
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK PEPPER (UNII: KM66971LVF) (BLACK PEPPER - UNII:KM66971LVF) BLACK PEPPER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-436-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-436-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-436-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-436-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PEANUT FOOD 
    peanut injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-433
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEANUT (UNII: QE1QX6B99R) (PEANUT - UNII:QE1QX6B99R) PEANUT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-433-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-433-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-433-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-433-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PECAN FOOD 
    pecan injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-435
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PECAN (UNII: F14P91GB5F) (PECAN - UNII:F14P91GB5F) PECAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-435-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-435-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-435-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-435-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PERCH 
    perch injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-438
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PERCH (UNII: 50Y07N9X03) (PERCH - UNII:50Y07N9X03) PERCH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-438-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-438-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-438-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-438-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BARLEY FOOD 
    barley injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-340
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BARLEY (UNII: 5PWM7YLI7R) (BARLEY - UNII:5PWM7YLI7R) BARLEY 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-340-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-340-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-340-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-340-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BUCKWHEAT 
    buckwheat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-358
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-358-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-358-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-358-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-358-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    OATS FOOD 
    oat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-418
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OAT (UNII: Z6J799EAJK) (OAT - UNII:Z6J799EAJK) OAT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-418-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-418-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-418-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-418-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    RICE FOOD 
    rice injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-452
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RICE (UNII: 659G217HPG) (RICE - UNII:659G217HPG) RICE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-452-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-452-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-452-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-452-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    RYE FOOD 
    rye injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-453
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RYE (UNII: 0R4AQI398X) (RYE - UNII:0R4AQI398X) RYE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-453-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-453-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-453-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-453-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    WHOLE WHEAT FOOD 
    wheat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-476
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WHEAT (UNII: 4J2I0SN84Y) (WHEAT - UNII:4J2I0SN84Y) WHEAT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-476-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-476-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-476-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-476-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PIMENTO 
    red bell pepper injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-439
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RED BELL PEPPER (UNII: E917XHH50V) (RED BELL PEPPER - UNII:E917XHH50V) RED BELL PEPPER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-439-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-439-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-439-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-439-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PORK 
    pork injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-443
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PORK (UNII: O138UB266J) (PORK - UNII:O138UB266J) PORK 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-443-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-443-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-443-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-443-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PACIFIC SALMON 
    pink salmon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-455
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINK SALMON (UNII: 9935G0V38C) (PINK SALMON - UNII:9935G0V38C) PINK SALMON 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-455-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-455-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-455-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-455-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PAPAYA 
    papaya injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-426
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PAPAYA (UNII: KU94FIY6JB) (PAPAYA - UNII:KU94FIY6JB) PAPAYA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-426-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-426-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-426-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-426-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SCALLOP 
    scallop injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-456
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SCALLOP (UNII: D380C73WOU) (SCALLOP - UNII:D380C73WOU) SCALLOP 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-456-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-456-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-456-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-456-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SHRIMP 
    shrimp injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-458
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SHRIMP (UNII: 1891LE191T) (SHRIMP - UNII:1891LE191T) SHRIMP 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-458-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-458-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-458-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-458-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SUNFLOWER SEED 
    sunflower seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-463
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SUNFLOWER SEED (UNII: R9N3379M4Z) (SUNFLOWER SEED - UNII:R9N3379M4Z) SUNFLOWER SEED 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-463-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-463-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-463-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-463-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BLACKEYED PEA 
    black-eyed pea injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-430
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK-EYED PEA (UNII: 786YV7B602) (BLACK-EYED PEA - UNII:786YV7B602) BLACK-EYED PEA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-430-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-430-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-430-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-430-50 10 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CORN FOOD 
    corn injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-381
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CORN (UNII: 0N8672707O) (CORN - UNII:0N8672707O) CORN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-381-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-381-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-381-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-381-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CACAO BEAN 
    cocoa injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-377
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCOA (UNII: D9108TZ9KG) (COCOA - UNII:D9108TZ9KG) COCOA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-377-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-377-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-377-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-377-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    COFFEE FOR DIAGNOSTIC USE ONLY 
    coffee bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-380
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COFFEE BEAN (UNII: JFH385Y744) (COFFEE BEAN - UNII:JFH385Y744) COFFEE BEAN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-380-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-380-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-380-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-380-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    BARLEY MALT 
    barley malt injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-410
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BARLEY MALT (UNII: R3NBG8914U) (BARLEY MALT - UNII:R3NBG8914U) BARLEY MALT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-410-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-410-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-410-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-410-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    CINNAMON 
    cinnamon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-374
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CINNAMON (UNII: 5S29HWU6QB) (CINNAMON - UNII:5S29HWU6QB) CINNAMON 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-374-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-374-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-374-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-374-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    DILL SEED 
    dill injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-388
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DILL (UNII: Y05PC4JZRH) (DILL - UNII:Y05PC4JZRH) DILL 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-388-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-388-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-388-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-388-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GARLIC 
    garlic injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-395
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GARLIC (UNII: V1V998DC17) (GARLIC - UNII:V1V998DC17) GARLIC 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-395-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-395-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-395-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-395-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    GINGER 
    ginger injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-397
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GINGER (UNII: C5529G5JPQ) (GINGER - UNII:C5529G5JPQ) GINGER 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-397-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-397-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-397-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-397-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    HORSERADISH 
    horseradish injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-405
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HORSERADISH (UNII: 8DS6G120HJ) (HORSERADISH - UNII:8DS6G120HJ) HORSERADISH 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-405-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-405-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-405-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-405-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    MUSTARD SEED 
    mustard seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-415
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUSTARD SEED (UNII: 58RXI817UT) (MUSTARD SEED - UNII:58RXI817UT) MUSTARD SEED 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-415-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-415-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-415-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-415-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    OREGANO 
    oregano injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-424
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OREGANO (UNII: 0E5AT8T16U) (OREGANO - UNII:0E5AT8T16U) OREGANO 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-424-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-424-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-424-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-424-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    PEPPERMINT 
    peppermint injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-486
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEPPERMINT (UNII: V95R5KMY2B) (PEPPERMINT - UNII:V95R5KMY2B) PEPPERMINT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-486-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-486-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-486-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-486-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    POPPY SEED 
    poppy seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-442
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPPY SEED (UNII: 60RO23IR87) (POPPY SEED - UNII:60RO23IR87) POPPY SEED 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-442-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-442-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-442-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-442-50 10 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SAGE FOOD 
    sage injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-454
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SAGE (UNII: 065C5D077J) (SAGE - UNII:065C5D077J) SAGE 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-454-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-454-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-454-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-454-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SESAME SEED 
    sesame seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-457
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SESAME SEED (UNII: 7Y1255HVXR) (SESAME SEED - UNII:7Y1255HVXR) SESAME SEED 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-457-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-457-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-457-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-457-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    SPEARMINT 
    spearmint injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-459
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SPEARMINT (UNII: J7I2T6IV1N) (SPEARMINT - UNII:J7I2T6IV1N) SPEARMINT 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-459-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-459-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-459-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-459-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    THYME 
    thyme injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-465
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    THYME (UNII: CW657OBU4N) (THYME - UNII:CW657OBU4N) THYME 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-465-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-465-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-465-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-465-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    VANILLA 
    vanilla injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-471
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    VANILLA (UNII: Q74T35078H) (VANILLA - UNII:Q74T35078H) VANILLA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-471-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-471-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-471-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-471-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102192 08/29/1972
    ALMOND 
    almond injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-333
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALMOND (UNII: 3Z252A2K9G) (ALMOND - UNII:3Z252A2K9G) ALMOND 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-333-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-333-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-333-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-333-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ACACIA POLLEN 
    acacia injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-901
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACACIA (UNII: 5C5403N26O) (ACACIA - UNII:5C5403N26O) ACACIA 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-901-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-901-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-901-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-901-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    RED ALDER POLLEN 
    alnus rubra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-902
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALNUS RUBRA POLLEN (UNII: Z0F2YK1B7H) (ALNUS RUBRA POLLEN - UNII:Z0F2YK1B7H) ALNUS RUBRA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-902-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-902-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-902-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-902-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    SMOOTH ALDER POLLEN 
    alnus incana subsp. rugosa pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-903
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALNUS INCANA SUBSP. RUGOSA POLLEN (UNII: 605T96G8Y5) (ALNUS INCANA SUBSP. RUGOSA POLLEN - UNII:605T96G8Y5) ALNUS INCANA SUBSP. RUGOSA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-903-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-903-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-903-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-903-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ARIZONA ASH POLLEN 
    fraxinus velutina pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-904
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FRAXINUS VELUTINA POLLEN (UNII: LJT6I6Z8FD) (FRAXINUS VELUTINA POLLEN - UNII:LJT6I6Z8FD) FRAXINUS VELUTINA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-904-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-904-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-904-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-904-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    GREEN RED ASH POLLEN 
    fraxinus pennsylvanica pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-905
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FRAXINUS PENNSYLVANICA POLLEN (UNII: 2WZG2G15WX) (FRAXINUS PENNSYLVANICA POLLEN - UNII:2WZG2G15WX) FRAXINUS PENNSYLVANICA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-905-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-905-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-905-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-905-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    WHITE ASH POLLEN 
    fraxinus americana pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-906
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FRAXINUS AMERICANA POLLEN (UNII: G684LX721Q) (FRAXINUS AMERICANA POLLEN - UNII:G684LX721Q) FRAXINUS AMERICANA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-906-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-906-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-906-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-906-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ASH MIX, GREEN/WHITE POLLEN 
    fraxinus americana pollen and fraxinus pennsylvanica pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-907
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FRAXINUS AMERICANA POLLEN (UNII: G684LX721Q) (FRAXINUS AMERICANA POLLEN - UNII:G684LX721Q) FRAXINUS AMERICANA POLLEN 0.5 g  in 20 mL
    FRAXINUS PENNSYLVANICA POLLEN (UNII: 2WZG2G15WX) (FRAXINUS PENNSYLVANICA POLLEN - UNII:2WZG2G15WX) FRAXINUS PENNSYLVANICA POLLEN 0.5 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-907-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-907-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-907-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-907-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    QUAKING ASPEN POLLEN 
    populus tremuloides pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-908
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS TREMULOIDES POLLEN (UNII: 928OC2TJDA) (POPULUS TREMULOIDES POLLEN - UNII:928OC2TJDA) POPULUS TREMULOIDES POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-908-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-908-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-908-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-908-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BAYBERRY POLLEN 
    morella cerifera pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-909
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MORELLA CERIFERA POLLEN (UNII: LC8MEV9S89) (MORELLA CERIFERA POLLEN - UNII:LC8MEV9S89) MORELLA CERIFERA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-909-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-909-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-909-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-909-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    AMERICAN BEECH POLLEN 
    fagus grandifolia pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-910
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FAGUS GRANDIFOLIA POLLEN (UNII: 34X886W1H4) (FAGUS GRANDIFOLIA POLLEN - UNII:34X886W1H4) FAGUS GRANDIFOLIA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-910-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-910-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-910-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-910-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BOX ELDER POLLEN 
    acer negundo pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-914
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER NEGUNDO POLLEN (UNII: P6K070AR8V) (ACER NEGUNDO POLLEN - UNII:P6K070AR8V) ACER NEGUNDO POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-914-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-914-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-914-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-914-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    MOUNTAIN CEDAR POLLEN 
    juniperus ashei pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-915
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS ASHEI POLLEN (UNII: 544F8MEY0Y) (JUNIPERUS ASHEI POLLEN - UNII:544F8MEY0Y) JUNIPERUS ASHEI POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-915-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-915-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-915-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-915-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    PINCHOT CEDAR POLLEN 
    juniperus pinchotii pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-916
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS PINCHOTII POLLEN (UNII: S8A4X05W7J) (JUNIPERUS PINCHOTII POLLEN - UNII:S8A4X05W7J) JUNIPERUS PINCHOTII POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-916-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-916-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-916-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-916-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    RED CEDAR POLLEN 
    juniperus virginiana pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-917
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS VIRGINIANA POLLEN (UNII: PY0JA16R2G) (JUNIPERUS VIRGINIANA POLLEN - UNII:PY0JA16R2G) JUNIPERUS VIRGINIANA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-917-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-917-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-917-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-917-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    EASTERN COTTONWOOD POLLEN 
    populus deltoides pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-919
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS DELTOIDES POLLEN (UNII: 476DVV63WP) (POPULUS DELTOIDES POLLEN - UNII:476DVV63WP) POPULUS DELTOIDES POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-919-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-919-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-919-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-919-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    WESTERN COTTONWOOD POLLEN 
    populus deltoides subsp. monilifera pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-920
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN (UNII: 5928LJ1441) (POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN - UNII:5928LJ1441) POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-920-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-920-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-920-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-920-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    COTTONWOOD MIX, EASTERN/WESTERN POLLEN 
    populus deltoides subsp. monilifera pollen and populus deltoides pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-921
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN (UNII: 5928LJ1441) (POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN - UNII:5928LJ1441) POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN 0.5 g  in 20 mL
    POPULUS DELTOIDES POLLEN (UNII: 476DVV63WP) (POPULUS DELTOIDES POLLEN - UNII:476DVV63WP) POPULUS DELTOIDES POLLEN 0.5 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-921-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-921-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-921-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-921-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ARIZONA CYPRESS POLLEN 
    cupressus arizonica pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-922
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUPRESSUS ARIZONICA POLLEN (UNII: 232DMH0XVF) (CUPRESSUS ARIZONICA POLLEN - UNII:232DMH0XVF) CUPRESSUS ARIZONICA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-922-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-922-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-922-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-922-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BALD CYPRESS POLLEN 
    taxodium distichum pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-923
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TAXODIUM DISTICHUM POLLEN (UNII: O12H03B41R) (TAXODIUM DISTICHUM POLLEN - UNII:O12H03B41R) TAXODIUM DISTICHUM POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-923-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-923-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-923-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-923-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    AMERICAN ELM POLLEN 
    ulmus americana pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-924
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ULMUS AMERICANA POLLEN (UNII: 89BAT511BD) (ULMUS AMERICANA POLLEN - UNII:89BAT511BD) ULMUS AMERICANA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-924-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-924-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-924-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-924-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    CEDAR FALL BLOOMING ELM POLLEN 
    ulmus crassifolia pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-925
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ULMUS CRASSIFOLIA POLLEN (UNII: G82398SD3I) (ULMUS CRASSIFOLIA POLLEN - UNII:G82398SD3I) ULMUS CRASSIFOLIA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-925-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-925-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-925-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-925-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    CHINESE SIBERIAN ELM POLLEN 
    ulmus pumila pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-926
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ULMUS PUMILA POLLEN (UNII: 030R993R8E) (ULMUS PUMILA POLLEN - UNII:030R993R8E) ULMUS PUMILA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-926-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-926-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-926-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-926-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ELM MIX, AMERICAN/CHINESE/SLIPPERY POLLEN 
    ulmus pumila pollen and ulmus americana pollen and ulmus rubra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-928
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ULMUS PUMILA POLLEN (UNII: 030R993R8E) (ULMUS PUMILA POLLEN - UNII:030R993R8E) ULMUS PUMILA POLLEN 0.33 g  in 20 mL
    ULMUS AMERICANA POLLEN (UNII: 89BAT511BD) (ULMUS AMERICANA POLLEN - UNII:89BAT511BD) ULMUS AMERICANA POLLEN 0.33 g  in 20 mL
    ULMUS RUBRA POLLEN (UNII: GHC6OHK0W0) (ULMUS RUBRA POLLEN - UNII:GHC6OHK0W0) ULMUS RUBRA POLLEN 0.34 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-928-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-928-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-928-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-928-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    EUCALYPTUS BLUE GUM POLLEN 
    eucalyptus globulus pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-929
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EUCALYPTUS GLOBULUS POLLEN (UNII: 7XW7TB10X9) (EUCALYPTUS GLOBULUS POLLEN - UNII:7XW7TB10X9) EUCALYPTUS GLOBULUS POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-929-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-929-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-929-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-929-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    DOUGLAS FIR POLLEN 
    pseudotsuga menziesii pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-930
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PSEUDOTSUGA MENZIESII POLLEN (UNII: ZEI09763J3) (PSEUDOTSUGA MENZIESII POLLEN - UNII:ZEI09763J3) PSEUDOTSUGA MENZIESII POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-930-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-930-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-930-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-930-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    SWEETGUM POLLEN 
    liquidambar styraciflua pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-932
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIQUIDAMBAR STYRACIFLUA POLLEN (UNII: 5Q246DS5BS) (LIQUIDAMBAR STYRACIFLUA POLLEN - UNII:5Q246DS5BS) LIQUIDAMBAR STYRACIFLUA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-932-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-932-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-932-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-932-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    HACKBERRY POLLEN 
    celtis occidentalis pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-933
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CELTIS OCCIDENTALIS POLLEN (UNII: 68R9X9Y96X) (CELTIS OCCIDENTALIS POLLEN - UNII:68R9X9Y96X) CELTIS OCCIDENTALIS POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-933-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-933-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-933-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-933-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    SHAGBARK HICKORY POLLEN 
    carya ovata pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-935
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARYA OVATA POLLEN (UNII: 54UN9R2798) (CARYA OVATA POLLEN - UNII:54UN9R2798) CARYA OVATA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-935-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-935-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-935-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-935-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    WHITE HICKORY POLLEN 
    carya tomentosa pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-936
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARYA TOMENTOSA POLLEN (UNII: G2A764T54B) (CARYA TOMENTOSA POLLEN - UNII:G2A764T54B) CARYA TOMENTOSA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-936-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-936-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-936-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-936-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    HICKORY MIX, PIGNUT/SHAGBARK/SHELLBARK/WHITE POLLEN 
    carya tomentosa pollen and carya laciniosa pollen and carya ovata pollen and carya glabra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-937
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARYA TOMENTOSA POLLEN (UNII: G2A764T54B) (CARYA TOMENTOSA POLLEN - UNII:G2A764T54B) CARYA TOMENTOSA POLLEN 0.25 g  in 20 mL
    CARYA LACINIOSA POLLEN (UNII: 5BGG872373) (CARYA LACINIOSA POLLEN - UNII:5BGG872373) CARYA LACINIOSA POLLEN 0.25 g  in 20 mL
    CARYA OVATA POLLEN (UNII: 54UN9R2798) (CARYA OVATA POLLEN - UNII:54UN9R2798) CARYA OVATA POLLEN 0.25 g  in 20 mL
    CARYA GLABRA POLLEN (UNII: KPO1Z9N98A) (CARYA GLABRA POLLEN - UNII:KPO1Z9N98A) CARYA GLABRA POLLEN 0.25 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-937-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-937-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-937-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-937-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ONE SEED JUNIPER POLLEN 
    juniperus monosperma pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-938
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS MONOSPERMA POLLEN (UNII: PM6E3FG1QK) (JUNIPERUS MONOSPERMA POLLEN - UNII:PM6E3FG1QK) JUNIPERUS MONOSPERMA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-938-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-938-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-938-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-938-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    ROCKY MOUNTAIN JUNIPER POLLEN 
    juniperus scopulorum pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-939
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS SCOPULORUM POLLEN (UNII: 0G82TT8ZFY) (JUNIPERUS SCOPULORUM POLLEN - UNII:0G82TT8ZFY) JUNIPERUS SCOPULORUM POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-939-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-939-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-939-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-939-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    RIVER BIRCH POLLEN 
    betula nigra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-912
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA NIGRA POLLEN (UNII: 93963RFO1P) (BETULA NIGRA POLLEN - UNII:93963RFO1P) BETULA NIGRA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-912-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-912-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-912-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-912-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BIRCH MIX, RIVER/PAPER/SWEET/WHITE POLLEN 
    betula nigra pollen and betula papyrifera pollen and betula lenta pollen and betula populifolia pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-913
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA NIGRA POLLEN (UNII: 93963RFO1P) (BETULA NIGRA POLLEN - UNII:93963RFO1P) BETULA NIGRA POLLEN 0.25 g  in 20 mL
    BETULA PAPYRIFERA POLLEN (UNII: 3538FNV8AY) (BETULA PAPYRIFERA POLLEN - UNII:3538FNV8AY) BETULA PAPYRIFERA POLLEN 0.25 g  in 20 mL
    BETULA LENTA POLLEN (UNII: JQ5HI5004M) (BETULA LENTA POLLEN - UNII:JQ5HI5004M) BETULA LENTA POLLEN 0.25 g  in 20 mL
    BETULA POPULIFOLIA POLLEN (UNII: 23H70FYJ5U) (BETULA POPULIFOLIA POLLEN - UNII:23H70FYJ5U) BETULA POPULIFOLIA POLLEN 0.25 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-913-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-913-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-913-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-913-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    WHITE GRAY BIRCH POLLEN 
    betula populifolia pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-940
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA POPULIFOLIA POLLEN (UNII: 23H70FYJ5U) (BETULA POPULIFOLIA POLLEN - UNII:23H70FYJ5U) BETULA POPULIFOLIA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-940-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-940-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-940-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-940-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    SUGAR HARD MAPLE POLLEN 
    acer saccharum pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-941
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER SACCHARUM POLLEN (UNII: V38QUQ7861) (ACER SACCHARUM POLLEN - UNII:V38QUQ7861) ACER SACCHARUM POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-941-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-941-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-941-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-941-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    MAPLE MIX, RED/SILVER/SUGAR POLLEN 
    acer saccharum pollen and acer saccharinum pollen and acer rubrum pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-943
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER SACCHARUM POLLEN (UNII: V38QUQ7861) (ACER SACCHARUM POLLEN - UNII:V38QUQ7861) ACER SACCHARUM POLLEN 0.33 g  in 20 mL
    ACER SACCHARINUM POLLEN (UNII: 95447163DG) (ACER SACCHARINUM POLLEN - UNII:95447163DG) ACER SACCHARINUM POLLEN 0.33 g  in 20 mL
    ACER RUBRUM POLLEN (UNII: 700NK45C76) (ACER RUBRUM POLLEN - UNII:700NK45C76) ACER RUBRUM POLLEN 0.34 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-943-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-943-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-943-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-943-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    MESQUITE POLLEN 
    prosopis juliflora pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-944
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PROSOPIS JULIFLORA POLLEN (UNII: 6EIJ3D04MR) (PROSOPIS JULIFLORA POLLEN - UNII:6EIJ3D04MR) PROSOPIS JULIFLORA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-944-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-944-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-944-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-944-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    PAPER MULBERRY POLLEN 
    broussonetia papyrifera pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-945
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROUSSONETIA PAPYRIFERA POLLEN (UNII: 51I6N3XIML) (BROUSSONETIA PAPYRIFERA POLLEN - UNII:51I6N3XIML) BROUSSONETIA PAPYRIFERA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-945-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-945-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-945-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-945-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    RED MULBERRY POLLEN 
    morus rubra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-946
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MORUS RUBRA POLLEN (UNII: 9LYI4RTZ52) (MORUS RUBRA POLLEN - UNII:9LYI4RTZ52) MORUS RUBRA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-946-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-946-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-946-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-946-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    WHITE MULBERRY POLLEN 
    morus alba pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-947
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MORUS ALBA POLLEN (UNII: 3I9T68187H) (MORUS ALBA POLLEN - UNII:3I9T68187H) MORUS ALBA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-947-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-947-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-947-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-947-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BLACK OAK POLLEN 
    quercus velutina pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-948
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS VELUTINA POLLEN (UNII: 294L626TT0) (QUERCUS VELUTINA POLLEN - UNII:294L626TT0) QUERCUS VELUTINA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-948-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-948-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-948-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-948-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BLACKJACK OAK POLLEN 
    quercus nigra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-949
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS NIGRA POLLEN (UNII: 6U600U1326) (QUERCUS NIGRA POLLEN - UNII:6U600U1326) QUERCUS NIGRA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-949-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-949-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-949-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-949-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    BUR OAK POLLEN 
    quercus macrocarpa pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-950
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS MACROCARPA POLLEN (UNII: 57BTU4547U) (QUERCUS MACROCARPA POLLEN - UNII:57BTU4547U) QUERCUS MACROCARPA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-950-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-950-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-950-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-950-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    LIVE OAK POLLEN 
    quercus virginiana pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-951
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS VIRGINIANA POLLEN (UNII: 8KDG09A4GO) (QUERCUS VIRGINIANA POLLEN - UNII:8KDG09A4GO) QUERCUS VIRGINIANA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-951-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-951-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-951-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-951-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    2-OAK MIX, RED/WHITE POLLEN 
    quercus rubra pollen and quercus alba pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-952
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS RUBRA POLLEN (UNII: SVW19ET93C) (QUERCUS RUBRA POLLEN - UNII:SVW19ET93C) QUERCUS RUBRA POLLEN 0.5 g  in 20 mL
    QUERCUS ALBA POLLEN (UNII: Z4Y9ZSV4KK) (QUERCUS ALBA POLLEN - UNII:Z4Y9ZSV4KK) QUERCUS ALBA POLLEN 0.5 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-952-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-952-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-952-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-952-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    5-OAK MIX, BLACKJACK/BUR/POST/RED/WHITE POLLEN 
    quercus nigra pollen and quercus macrocarpa pollen and quercus stellata pollen and quercus rubra pollen and quercus alba pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-954
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS NIGRA POLLEN (UNII: 6U600U1326) (QUERCUS NIGRA POLLEN - UNII:6U600U1326) QUERCUS NIGRA POLLEN 0.20 g  in 20 mL
    QUERCUS MACROCARPA POLLEN (UNII: 57BTU4547U) (QUERCUS MACROCARPA POLLEN - UNII:57BTU4547U) QUERCUS MACROCARPA POLLEN 0.20 g  in 20 mL
    QUERCUS STELLATA POLLEN (UNII: W34X0P8636) (QUERCUS STELLATA POLLEN - UNII:W34X0P8636) QUERCUS STELLATA POLLEN 0.20 g  in 20 mL
    QUERCUS RUBRA POLLEN (UNII: SVW19ET93C) (QUERCUS RUBRA POLLEN - UNII:SVW19ET93C) QUERCUS RUBRA POLLEN 0.20 g  in 20 mL
    QUERCUS ALBA POLLEN (UNII: Z4Y9ZSV4KK) (QUERCUS ALBA POLLEN - UNII:Z4Y9ZSV4KK) QUERCUS ALBA POLLEN 0.20 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-954-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-954-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-954-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-954-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    3-OAK MIX, BLACK/BLACKJACK/POST POLLEN 
    quercus velutina pollen and quercus nigra pollen and quercus stellata pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-953
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS VELUTINA POLLEN (UNII: 294L626TT0) (QUERCUS VELUTINA POLLEN - UNII:294L626TT0) QUERCUS VELUTINA POLLEN 0.33 g  in 20 mL
    QUERCUS NIGRA POLLEN (UNII: 6U600U1326) (QUERCUS NIGRA POLLEN - UNII:6U600U1326) QUERCUS NIGRA POLLEN 0.33 g  in 20 mL
    QUERCUS STELLATA POLLEN (UNII: W34X0P8636) (QUERCUS STELLATA POLLEN - UNII:W34X0P8636) QUERCUS STELLATA POLLEN 0.34 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-953-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-953-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-953-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-953-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    POST OAK POLLEN 
    quercus stellata pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-955
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS STELLATA POLLEN (UNII: W34X0P8636) (QUERCUS STELLATA POLLEN - UNII:W34X0P8636) QUERCUS STELLATA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-955-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-955-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-955-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-955-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    QUEEN PALM POLLEN 
    syagrus romanzoffiana pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-956
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SYAGRUS ROMANZOFFIANA POLLEN (UNII: 84ZOM591BB) (SYAGRUS ROMANZOFFIANA POLLEN - UNII:84ZOM591BB) SYAGRUS ROMANZOFFIANA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-956-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-956-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-956-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-956-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    EUROPEAN OLIVE POLLEN 
    olea europaea pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-957
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OLEA EUROPAEA POLLEN (UNII: 43R41XZ627) (OLEA EUROPAEA POLLEN - UNII:43R41XZ627) OLEA EUROPAEA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-957-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-957-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-957-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-957-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    DATE PALM POLLEN 
    phoenix dactylifera pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-959
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PHOENIX DACTYLIFERA POLLEN (UNII: 2FV55IRB5B) (PHOENIX DACTYLIFERA POLLEN - UNII:2FV55IRB5B) PHOENIX DACTYLIFERA POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-959-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-959-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-959-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-959-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    PECAN POLLEN 
    carya illinoinensis pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-960
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARYA ILLINOINENSIS POLLEN (UNII: PYO4JR720Y) (CARYA ILLINOINENSIS POLLEN - UNII:PYO4JR720Y) CARYA ILLINOINENSIS POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-960-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-960-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-960-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-960-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    WHITE PINE POLLEN 
    pinus strobus pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-962
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINUS STROBUS POLLEN (UNII: TX1ER5UV3T) (PINUS STROBUS POLLEN - UNII:TX1ER5UV3T) PINUS STROBUS POLLEN 1 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-962-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-962-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-962-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-962-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    4-PINE MIX, AUSTRIAN/LOBLOLLY/SCOTCH/WHITE POLLEN 
    pinus strobus pollen and pinus sylvestris pollen and pinus taeda pollen and pinus nigra pollen injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54575-963
    Route of Administration PERCUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINUS STROBUS POLLEN (UNII: TX1ER5UV3T) (PINUS STROBUS POLLEN - UNII:TX1ER5UV3T) PINUS STROBUS POLLEN 0.25 g  in 20 mL
    PINUS SYLVESTRIS POLLEN (UNII: 59070I8M63) (PINUS SYLVESTRIS POLLEN - UNII:59070I8M63) PINUS SYLVESTRIS POLLEN 0.25 g  in 20 mL
    PINUS TAEDA POLLEN (UNII: 4O1FFR8ARN) (PINUS TAEDA POLLEN - UNII:4O1FFR8ARN) PINUS TAEDA POLLEN 0.25 g  in 20 mL
    PINUS NIGRA POLLEN (UNII: 17Q05812N1) (PINUS NIGRA POLLEN - UNII:17Q05812N1) PINUS NIGRA POLLEN 0.25 g  in 20 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.166 g  in 100 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.091 g  in 100 mL
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX) 50 mL  in 100 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:54575-963-02 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:54575-963-10 10 mL in 1 VIAL, MULTI-DOSE
    3 NDC:54575-963-30 30 mL in 1 VIAL, MULTI-DOSE
    4 NDC:54575-963-50 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA101376 12/07/1967
    LOM